Obstetrics & gynaecology

First-trimester biomarker may help identify early GDM risk

(HealthDay)—Glycosylated fibronectin may be able to identify pregnant women during the first trimester at risk for developing gestational diabetes mellitus (GDM), according to a study published online Aug. 5 in Obstetrics ...


New test assesses gestational diabetes risk early in pregnancy

Levels of a biomarker in a pregnant woman's blood can help physicians gauge her risk of developing gestational diabetes during the first trimester, according to a recent study accepted for publication in The Endocrine Society's ...

page 1 from 4